Colorectal cancer
Conditions
Interventions
Sponsors
Tianjin Third Central Hospital
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: ? between 40 and 75 years old; ? Patients diagnosed with colon cancer, rectal cancer or colon cancer combined with rectal cancer by total colorectal colonoscopy and histopathological biopsy, and who received elective laparoscopic radical resection of colorectal cancer for the first time; ? Meet the indication of radical resection (limited to laparoscopic surgery); ?ECOG-PS score 0-1; (5) Expected survival =6 months; ? Subjects voluntarily participate and sign informed consent.
Exclusion criteria
Exclusion criteria: Patients with any of the following conditions are not allowed to enter or continue the study: ? Have a history of immunosuppressive drugs or a history of immune deficiency; ? Have seen other clinical experimenters in the last three months; ? Patients with previous malignant tumors <5 years; ? Patients who have received other surgical treatment for less than 6 months; (5) Women who are breastfeeding, pregnant or planning to become pregnant; ? Patients who are known to be allergic to test sample components or their analogues; 7 Patients with contraindications to abdominal perfusion; 8 Patients with cognitive impairment or poor treatment compliance determined by researchers; Other severe, acute, or chronic medical conditions that may interfere with the findings; ? Other conditions deemed unsuitable for inclusion or inappropriate for clinical experimenter by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immune cell subsets;Postoperative complication; | — |
Secondary
| Measure | Time frame |
|---|---|
| Average length of stay; | — |
Countries
China
Contacts
Public ContactWang Ximo
Tianjin Third Central Hospital
Outcome results
None listed